Marina Lima Rodrigues
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marina Lima Rodrigues has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Anderson Jesus Gomes
Laboratory of Photochemistry and Nanobiotechnology University of Brasília Brasília Brazil
1 shared publication - Claure Nain Lunardi
Laboratory of Photochemistry and Nanobiotechnology University of Brasília Brasília Brazil
1 shared publication - Danielle Galdino de Souza
University of Brasilia
1 shared publication - José Athayde Vasconcelos Morais
University of Brasilia
1 shared publication - Maria das Neves Martins
Faculdade de ciências da saúde de unai
1 shared publication Mirella P. F. Barros
University of Brasilia
1 shared publication
Latest Publications
- Open Access
- 2 October 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (13)
Modulation of Chloroquine in nanoparticle uptake: a review
The application of nanotechnology in several areas of medicine has been promising, however, there are still serious problems, such as in the area of oncology, for example. Although nanoparticles can accumulate 10 times more in tumors, less than 1% of the injected dose actually reaches the tumor, as they are retained mainly in the liver and spleen. Liver-specific macrophages, called Kupffer cells, are one of the main barriers to the use of nanoparticles for cancer treatment. These Kupffer Cells are part of the Mononuclear Phagocytic System (MPS) and exhibit endocytic activity against materials that pass through the blood and enter the liver. For this reason, Kupffer cells are central to the process of eliminating nanoparticles that cross the body's epithelial barriers. Still, chloroquine can act directly on the MPS, helping the nanoparticles reach their final target. This review addresses the main studies with chloroquine acting in the MPS, which could revolutionize cancer treatment or other biological applications.
- 2 October 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (13)
Open AccessModulation of Chloroquine in nanoparticle uptake: a review
The application of nanotechnology in several areas of medicine has been promising, however, there are still serious problems, such as in the area of oncology, for example. Although nanoparticles can accumulate 10 times more in tumors, less than 1% of the injected dose actually reaches the tumor, as they are retained mainly in the liver and spleen. Liver-specific macrophages, called Kupffer cells, are one of the main barriers to the use of nanoparticles for cancer treatment. These Kupffer Cells are part of the Mononuclear Phagocytic System (MPS) and exhibit endocytic activity against materials that pass through the blood and enter the liver. For this reason, Kupffer cells are central to the process of eliminating nanoparticles that cross the body's epithelial barriers. Still, chloroquine can act directly on the MPS, helping the nanoparticles reach their final target. This review addresses the main studies with chloroquine acting in the MPS, which could revolutionize cancer treatment or other biological applications.
- 16 June 2018
- Published by Springer Nature in Gold Bulletin
- Vol. 51 (4) , 131-137
Synthesis of gold nanoparticles using Euphorbia tirucalli latex and the microwave method
- 16 June 2018
- Published by Springer Nature in Gold Bulletin
- Vol. 51 (4) , 131-137
Synthesis of gold nanoparticles using Euphorbia tirucalli latex and the microwave method